HI
GCVRZ

Hudock Inc’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Hudock Inc’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-43
Closed – – 730
2017
Q4 		$0 Hold
43
– – ﹤0.01% 714
2017
Q3 		$0 Hold
43
– – ﹤0.01% 709
2017
Q2 		$0 Hold
43
– – ﹤0.01% 661
2017
Q1 		$0 Hold
43
– – ﹤0.01% 620
2016
Q4 		$0 Sell
43
-217
-83% -$73 ﹤0.01% 628
2016
Q3 		$0 Hold
260
– – ﹤0.01% 640
2016
Q2 		$0 Hold
260
– – ﹤0.01% 646
2016
Q1 		$0 Hold
260
– – ﹤0.01% 647
2015
Q4 		$0 Hold
260
– – ﹤0.01% 629
2015
Q3 		$0 Hold
260
– – ﹤0.01% 642
2015
Q2 		$0 Hold
260
– – ﹤0.01% 641
2015
Q1 		$0 Hold
260
– – ﹤0.01% 637
2014
Q4 		$0 Hold
260
– – ﹤0.01% 617
2014
Q3 		$0 Hold
260
– – ﹤0.01% 643
2014
Q2 		$0 Hold
260
– – ﹤0.01% 644
2014
Q1 		$0 Hold
260
– – ﹤0.01% 626
2013
Q4 		$0 Hold
260
– – ﹤0.01% 615
2013
Q3 		$1K Hold
260
– – ﹤0.01% 521
2013
Q2 		$0 Buy
+260
New +$457 ﹤0.01% 549

Other funds holding GCVRZ

SCM
Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return
EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
MCM
Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
BCM
Brigade Capital Management New York $806M AUM 20.71% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return
NGA
New Generation Advisors Manchester, Massachusetts $45.6M AUM 15.43% 1-Year Est. Return

Hudock Inc's GCVRZ Position: Q1 2018 in Review

Hudock Inc sold out of Sanofi Contingent Value Rights (GCVRZ) in Q1 2018, closing a stake of 43 shares.

Hudock Inc first reported a position in GCVRZ in Q2 2013 and held it in 19 quarters. The position peaked at $1K in Q3 2013. 100 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2018.

  • Hudock Inc reported no remaining Sanofi Contingent Value Rights position as of Q1 2018 after selling out during the quarter.
  • Hudock Inc sold 43 Sanofi Contingent Value Rights shares in Q1 2018.
  • Hudock Inc first reported a position in Sanofi Contingent Value Rights in Q2 2013 and held it in 19 quarters.
  • Hudock Inc's Sanofi Contingent Value Rights position peaked at $1K in Q3 2013.
  • 100 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2018.

Based on Hudock Inc's 13F filing for Q1 2018, filed 27 Apr 2018.